Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2006 1
2007 2
2008 2
2013 2
2014 1
2015 1
2016 4
2017 1
2019 1
2021 1
2022 1
2023 2
2024 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

20 results

Results by year

Filters applied: . Clear all
Page 1
Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Davies C, Pan H, Godwin J, Gray R, Arriagada R, Raina V, Abraham M, Medeiros Alencar VH, Badran A, Bonfill X, Bradbury J, Clarke M, Collins R, Davis SR, Delmestri A, Forbes JF, Haddad P, Hou MF, Inbar M, Khaled H, Kielanowska J, Kwan WH, Mathew BS, Mittra I, Müller B, Nicolucci A, Peralta O, Pernas F, Petruzelka L, Pienkowski T, Radhika R, Rajan B, Rubach MT, Tort S, Urrútia G, Valentini M, Wang Y, Peto R; Adjuvant Tamoxifen: Longer Against Shorter (ATLAS) Collaborative Group. Davies C, et al. Lancet. 2013 Mar 9;381(9869):805-16. doi: 10.1016/S0140-6736(12)61963-1. Lancet. 2013. PMID: 23219286 Free PMC article. Clinical Trial.
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey.
Reni M, Giommoni E, Bergamo F, Milella M, Cavanna L, Di Marco MC, Spada M, Cordio S, Aprile G, Cardellino GG, Maiello E, Bernardini I, Ghidini M, Bozzarelli S, Macchini M, Orsi G, De Simone I, Rulli E, Porcu L, Torri V, Pinto C; GARIBALDI Study Group. Reni M, et al. ESMO Open. 2023 Feb;8(1):100777. doi: 10.1016/j.esmoop.2022.100777. Epub 2023 Feb 1. ESMO Open. 2023. PMID: 36731325 Free PMC article.
Tas-102 for Refractory Metastatic Colorectal Cancer: A Multicenter Retrospective Cohort Study.
Conti M, Bolzacchini E, Luchena G, Bertu' L, Tagliabue P, Aglione S, Ardizzoia A, Arnoffi J, Guida FM, Bertolini A, Pastorini A, Duro M, Bettega D, Roda' G, Artale S, Squizzato A, Giordano M. Conti M, et al. Among authors: luchena g. Cancers (Basel). 2023 Jul 2;15(13):3465. doi: 10.3390/cancers15133465. Cancers (Basel). 2023. PMID: 37444575 Free PMC article.
A randomized phase III study of fractionated docetaxel, oxaliplatin, capecitabine (low-tox) vs epirubicin, oxaliplatin and capecitabine (eox) in patients with locally advanced unresectable or metastatic gastric cancer: the lega trial.
Rosati G, Cella CA, Cavanna L, Codecà C, Prisciandaro M, Mosconi S, Luchena G, Silvestris N, Bernardini I, Casaretti R, Zoratto F, Amoroso D, Ciarlo A, Barni S, Cascinu S, Davite C, Di Sanzo A, Casolaro A, Bilancia D, Labianca R. Rosati G, et al. Among authors: luchena g. Gastric Cancer. 2022 Jul;25(4):783-793. doi: 10.1007/s10120-022-01292-y. Epub 2022 Mar 30. Gastric Cancer. 2022. PMID: 35352176 Clinical Trial.
Exploring external validity of chemotherapy for pancreatic ductal adenocarcinoma in real life.
Reni M, Giordano G, Audisio M, Orsi G, Macchini M, Gobba SM, Rapposelli I, Lucenti A, Luchena G, Faloppi L, Zustovich F, Ricci V, Cergnul M, Formica V, Procaccio L, Baccolini V, Briccolani A, Cascinu S, Peretti U. Reni M, et al. Among authors: luchena g. Dig Liver Dis. 2024 Jul 12:S1590-8658(24)00835-1. doi: 10.1016/j.dld.2024.06.025. Online ahead of print. Dig Liver Dis. 2024. PMID: 39003164
Safety Report of TAS-102 in a Patient With Reduced DPD Activity.
Bolzacchini E, Luchena G, Giordano M. Bolzacchini E, et al. Among authors: luchena g. Clin Colorectal Cancer. 2019 Dec;18(4):310-312. doi: 10.1016/j.clcc.2019.07.008. Epub 2019 Jul 29. Clin Colorectal Cancer. 2019. PMID: 31421985 No abstract available.
Systematic versus on-demand early palliative care: results from a multicentre, randomised clinical trial.
Maltoni M, Scarpi E, Dall'Agata M, Zagonel V, Bertè R, Ferrari D, Broglia CM, Bortolussi R, Trentin L, Valgiusti M, Pini S, Farolfi A, Casadei Gardini A, Nanni O, Amadori D; Early Palliative Care Italian Study Group (EPCISG). Maltoni M, et al. Eur J Cancer. 2016 Sep;65:61-8. doi: 10.1016/j.ejca.2016.06.007. Epub 2016 Jul 26. Eur J Cancer. 2016. PMID: 27472648 Free article. Clinical Trial.
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey.
Reni M, Giommoni E, Bergamo F, Cavanna L, Simionato F, Spada M, Di Marco M, Bernardini I, Cordio SS, Latiano T, Spallanzani A, Silvestris N, Cardellino GG, Bonomi M, Milella M, Luchena G, Tamburini E, Macchini M, Orsi G, Modesti M, Procaccio L, Santoni A, De Simone I, Caldirola L, Galli F, Pinto C. Reni M, et al. Among authors: luchena g. Pancreatology. 2024 Nov;24(7):1160-1166. doi: 10.1016/j.pan.2024.10.002. Epub 2024 Oct 3. Pancreatology. 2024. PMID: 39389862 Free article.
Baseline Characteristics and Outcomes of Cancer Patients Infected with SARS-CoV-2 in the Lombardy Region, Italy (AIOM-L CORONA): A Multicenter, Observational, Ambispective, Cohort Study.
Di Cosimo S, Tagliaferri B, Generali D, Giudici F, Agustoni F, Bernardo A, Borgonovo K, Farina G, Luchena G, Luciani A, Nolè F, Palmeri L, Pietrantonio F, Poggi G, Zucali PA, Balletti E, Catania G, Bernocchi O, D'Antonio F, Giordano M, Grossi F, Lasagna A, La Verde N, Manzoni M, Montagna B, Olgiati A, Raimondi A, Rampinelli I, Verri E, Zaniboni A, Di Maio M, Beretta G, Danova M. Di Cosimo S, et al. Among authors: luchena g. Cancers (Basel). 2021 Mar 16;13(6):1324. doi: 10.3390/cancers13061324. Cancers (Basel). 2021. PMID: 33809465 Free PMC article.
A randomized trial of intensive versus minimal surveillance of patients with resected Dukes B2-C colorectal carcinoma.
Rosati G, Ambrosini G, Barni S, Andreoni B, Corradini G, Luchena G, Daniele B, Gaion F, Oliverio G, Duro M, Martignoni G, Pinna N, Sozzi P, Pancera G, Solina G, Pavia G, Pignata S, Johnson F, Labianca R, Apolone G, Zaniboni A, Monteforte M, Negri E, Torri V, Mosconi P, Fossati R; GILDA working group. Rosati G, et al. Among authors: luchena g. Ann Oncol. 2016 Feb;27(2):274-80. doi: 10.1093/annonc/mdv541. Epub 2015 Nov 16. Ann Oncol. 2016. PMID: 26578734 Free article. Clinical Trial.
20 results